PMGC HOLDINGS INC. Income (Loss) from Continuing Operations, Per Basic Share
PMGC HOLDINGS INC. (ELAB) reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.61 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2026-08-14
- PMGC HOLDINGS INC. income (loss) from continuing operations, per basic share for the quarter ending 2026-06-30 was -$0.61.
- PMGC HOLDINGS INC. income (loss) from continuing operations, per basic share for the quarter ending 2026-03-31 was -$11.22.
- PMGC HOLDINGS INC. income (loss) from continuing operations, per basic share for the quarter ending 2025-09-30 was -$4.95.
- PMGC HOLDINGS INC. income (loss) from continuing operations, per basic share for the quarter ending 2025-06-30 was -$39.14.
- PMGC HOLDINGS INC. income (loss) from continuing operations, per basic share for fiscal 2025 was -$382.30.
- PMGC HOLDINGS INC. income (loss) from continuing operations, per basic share for fiscal 2024 was -$4239.70.
- PMGC HOLDINGS INC. income (loss) from continuing operations, per basic share for fiscal 2023 was -$215.83.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 6 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Basic Share 9 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month | Income (Loss) from Continuing Operations, Per Basic Share 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.61 10-Q · filed 2026-08-14 | -$2.97 10-Q · filed 2026-08-14 | |||||
| 2026-03-31 | -$11.22 10-Q · filed 2026-05-15 | ||||||
| 2025-12-31 | -$382.30 10-K · filed 2026-03-30 | ||||||
| 2025-09-30 | -$4.95 10-Q · filed 2025-11-14 | -$13.73 10-Q · filed 2025-11-14 | |||||
| 2025-06-30 | -$39.14 10-Q · filed 2026-08-14 | -$0.47 10-Q · filed 2025-08-13 | -$202.48 10-Q · filed 2026-08-14 | -$2.41 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | -$243.76 10-Q · filed 2026-05-15 | -$2.90 10-Q · filed 2025-05-14 | |||||
| 2024-12-31 | -$4239.70 10-K · filed 2026-03-30 | -$50.47 10-K · filed 2025-03-28 | |||||
| 2024-09-30 | -$265.78 10-Q · filed 2025-11-14 | -$589.61 10-Q · filed 2025-11-14 | |||||
| 2024-06-30 | -$42.30 10-Q · filed 2025-08-13 | -$86.22 10-Q · filed 2025-08-13 | |||||
| 2024-03-31 | -$43.94 10-Q · filed 2025-05-14 | ||||||
| 2023-12-31 | -$215.83 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |